Kazuo Fujihara1,2, Yoshito Nagano3, Yoshikazu Naito4, Hideaki Hida4, Saori Yamauchi4, Muneyoshi Kudo4, Satoshi Yuki4, Shinya Hirota4, Kyoko Kato4 (1.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 2.Southern TOHOKU Research Institute for Neuroscience, Japan, 3.Shion Daini Clinic, Japan, 4.Mitsubishi Tanabe Pharma Corporation, Japan)
Session information
Japanese Poster Session
Japanese
[Pj-015] Japanese Poster Session 015「Neuroimmunology: NMOSD and MOGAD 1」
Wed. May 29, 2024 5:20 PM - 6:40 PM Poster (Hall E, E Block, B2F, TIF)
Chair(s): Akihiro Ueda (Fujita Health University School of Medicine, Department of Neurology, Japan)
Shinya Hirota1, Kyoko Kato1, Yoshikazu Naito1, Yoshito Nagano2, Hideaki Hida1, Saori Yamauchi1, Muneyoshi Kudo1, Satoshi Yuki1, Kazuo Fujihara3,4 (1.Mitsubishi Tanabe Pharma Corporation, Japan, 2.Shion Daini Clinic, Japan, 3.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan, 4.Southern TOHOKU Research Institute for Neuroscience, Japan)
Akihiro Ueda1,2, Sayuri Shima2, Toshiki Maeda2, Masami Mizuno2, Reiko Odake2, Akira Sato1, Yuji Tsujimura2, Konoka Kanda2, Syoko Nakano2, Kunihisa Kato2, Atsuhiro Higashi2, Koichi Kikuchi2, Ryunosuke Nagao2, Seiko Hirota2, Tomomasa Ishikawa1, Yasuaki Mizutani2, Mizuki Ito2,3, Shinji Ito1, Tatsuro Mutoh2,4, Hirohisa Watanabe2 (1.Fujita Health University Okazaki Medical Center, Japan, 2.Fujita Health University School of Medicine Department of Neurology, Japan, 3.Fujita Health University Bantane Hospital, Japan, 4.Fujita Health University Central Japan internasional Airport Clinic, Japan)
Yurino Horiuchi1, Atsuko Katsumoto1, Tomoko Okamoto1, Youwei Lin1,2, Wakiro Sato2, Takashi Yamamura2, Yuji Takahashi1 (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)
Yasuhiro Hamada1,2, Masashi Kino2,3, Tadayuki Takata1,2, Keita Takaba2, Yuta Chiba4, Jun Kurimoto5, Shingo Aoe6, Yohei Kokudo4, Masaki Kamada2,3, Wakako Nonaka2,7, Makoto Kita2, Kisaki Tachi2, Tetsuo Touge2, Kazushi Deguchi2, Tsutomu Masaki2 (1.Department of Supportive and Promotive Medicine of the Municipal Hospital, Faculty of Medicine, Kagawa University, Japan, 2.Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Japan, 3.Department of Neurological Intractable Disease Research, Faculty of Medicine, Kagawa University, Japan, 4.National Hospital Organization Takamatsu Medical Center, Japan, 5.Sanuki Municipal Hospital, Japan, 6.Sakaide Saint Martin's Hospital, Japan, 7.Department of General Medicine, Faculty of Medicine, Kagawa University, Japan)
Chikashi Yano, Eiji Matsuura, Tomonori Nakamura, Masahiro Ando, Yu Hiramatsu, Satoshi Nozuma, Yujiro Higuchi, Yusuke Sakiyama, Akihiro Hashiguchi, Kumiko Michizono, Keiko Higashi, Hiroshi Takashima (Department of Neurology, Kagoshima University Hospital, Japan)